The largest study so far, published in JAMA Ophthalmology on 1 March this year, followed more than 1,02,000 US veterans with type 2 diabetes for up to 7.5 years and found semaglutide users had a twofold higher risk of NAION compared to those who started an SGLT2 inhibitor, with NAION developing in 0.29 percent of semaglutide users versus 0.13 percent of the comparator group
Take our free peptide quiz and get a personalized recommendation in 2 minutes
Outside of young people's family/guardianship and upbringing, it is generally recognized that early-stage education is critical for establishing long-term, health-related knowledge, skills, and competencies to achieve health policies
The efficacy and safety of -nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial